NBI-1070770

N/A

Report date: 2025/03/03 16:52:10

NME

Base Information

Drug NameNBI-1070770

Drug Alias NameNBI-1070770NBI-'770NBI-770

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 modulators

TargetsGlutamate [NMDA] receptor subunit epsilon 2

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDepressive Disorder, Major

Inactive IndicationsN/A

ATC CodeN/A